Glazer Capital LLC’s Aratana Therapeutics, Inc. PETX Stock Holding History

Glazer Capital LLC’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85,000	Closed	-$439K	–	225
2019 Q2	$439K	Buy	+85,000	New	+$382K	0.05%	113

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Glazer Capital LLC's PETX Position: Q3 2019 in Review

Glazer Capital LLC sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 85,000 shares — an estimated $439K sold.

Glazer Capital LLC first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $439K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Glazer Capital LLC reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Glazer Capital LLC sold 85,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $439K.
Glazer Capital LLC first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Glazer Capital LLC's Aratana Therapeutics, Inc. position peaked at $439K in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Glazer Capital LLC's 13F filing for Q3 2019, filed 14 Nov 2019.